Surfactin from Bacillus subtilis displays anti-proliferative effect via apoptosis induction, cell cycle arrest and survival signaling suppression

FEBS Lett. 2007 Mar 6;581(5):865-71. doi: 10.1016/j.febslet.2007.01.059. Epub 2007 Feb 2.

Abstract

The effect of surfactin on the proliferation of LoVo cells, a human colon carcinoma cell line, was examined. Surfactin strongly blocked the proliferation of LoVo cells by inducing pro-apoptotic activity and arresting the cell cycle, according to several lines of evidence on DNA fragmentation, Annexin V staining, and altered levels of poly (ADP-ribose) polymerase, caspase-3, p21(WAF1/Cip1), p53, CDK2 and cyclin E. The anti-proliferative activity of surfactin was mediated by inhibiting extracellular-related protein kinase and phosphoinositide 3-kinase/Akt activation, as assessed by phosphorylation levels. Therefore, our data suggest that surfactin may have anti-cancer properties as a result of its ability to downregulate the cell cycle and suppress its survival.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antineoplastic Agents / isolation & purification
  • Antineoplastic Agents / pharmacology*
  • Apoptosis / drug effects*
  • Bacillus subtilis / chemistry*
  • Caspase 3 / metabolism
  • Cell Cycle / drug effects*
  • Cell Line, Tumor
  • Cell Proliferation / drug effects
  • Cell Survival / drug effects
  • Collagen Type XI / metabolism
  • Fas Ligand Protein / metabolism
  • Humans
  • Lipopeptides
  • Peptides, Cyclic / isolation & purification
  • Peptides, Cyclic / pharmacology*
  • Signal Transduction / drug effects
  • fas Receptor / metabolism

Substances

  • Antineoplastic Agents
  • COL11A2 protein, human
  • Collagen Type XI
  • FAS protein, human
  • Fas Ligand Protein
  • Lipopeptides
  • Peptides, Cyclic
  • fas Receptor
  • surfactin peptide
  • Caspase 3